Background Intestinal 18F-FDG Uptake Is Related to Serum Lipid Profile and Obesity in Breast Cancer Patients

作者: Hai-Jeon Yoon , Han-Na Kim , Yeojun Yun , Yemi Kim , Ae-Na Ha

DOI: 10.1371/JOURNAL.PONE.0141473

关键词:

摘要: Background This study investigated the relationships between background intestinal uptake on 18F–FDG PET and cardio-metabolic risk (CMR) factors. Methods A total of 326 female patients that underwent to determine initial stage breast cancer were enrolled. None had history diabetes or hypertension. The was visually graded (low vs. high group) quantitatively measured using maximal standardized value (SUVmax). SUVmax 7 bowel segments (duodenum, jejunum, ileum, cecum, hepatic flexure, splenic descending colon-sigmoid junction) averaged for (TB SUVmax). Age, body mass index (BMI), fasting blood glucose level (BST), triglyceride (TG), cholesterol, density lipoprotein (HDL), low (LDL) considered CMR factors. diverse factors analyzed. Results The visual grades based classified 100 (30.7%) into group, while 226 (69.3%) group. Among factors, age (p = 0.004), BMI (p<0.001), TG (p<0.001) significantly different according grade uptake. Quantitative TB showed significant positive correlation with (r 0.203, p<0.001), 0.373, 0.338, cholesterol 0.148, p 0.008), LDL 0.143, 0.024) negative HDL -0.147, 0.022). Multivariate analysis indicated independent in both 0.027 0.023, respectively) 0.006 0.004, respectively). Conclusion Increased may suggest alteration lipid metabolism disease non-diabetic non-hypertensive patients.

参考文章(26)
Wakoh Takahashi, Shigeharu Takagi, Michiru Ide, Seiei Yasuda, Hirofumi Fujii, Akira Shohtsu, Factors influencing physiological FDG uptake in the intestine. The Tokai journal of experimental and clinical medicine. ,vol. 23, pp. 241- 244 ,(1998)
F Fava, JA Lovegrove, R Gitau, KG Jackson, KM Tuohy, The gut microbiota and lipid metabolism: implications for human health and coronary heart disease. Current Medicinal Chemistry. ,vol. 13, pp. 3005- 3021 ,(2006) , 10.2174/092986706778521814
Onil K. Bhattacharyya, Lawrence A. Leiter, Ananda Chatterjee, Stewart B. Harris, David H. Fitchett, Hwee Teoh, Managing cardiometabolic risk in primary care: summary of the 2011 consensus statement. Canadian Family Physician. ,vol. 58, pp. 389- 393 ,(2012)
Urmila Maitra, Lu Gan, Samantha Chang, Liwu Li, Low-dose endotoxin induces inflammation by selectively removing nuclear receptors and activating CCAAT/enhancer-binding protein δ. Journal of Immunology. ,vol. 186, pp. 4467- 4473 ,(2011) , 10.4049/JIMMUNOL.1003300
Kristina Harris, Amira Kassis, Geneviève Major, Chieh J. Chou, Is the Gut Microbiota a New Factor Contributing to Obesity and Its Metabolic Disorders Journal of Obesity. ,vol. 2012, pp. 879151- 879151 ,(2012) , 10.1155/2012/879151
Kristina Harris, Amira Kassis, Geneviève Major, Chieh J. Chou, Erratum to “Is the Gut Microbiota a New Factor Contributing to Obesity and Its Metabolic Disorders?” Journal of Obesity. ,vol. 2012, pp. 1- 1 ,(2012) , 10.1155/2012/782920
David P. Rose, Gina Day Stephenson, Breast cancer and obesity: an update. Nutrition and Cancer. ,vol. 45, pp. 1- 16 ,(2003) , 10.1207/S15327914NC4501_1
C.J. Bailey, K.J. Mynett, T. Page, Importance of the intestine as a site of metformin-stimulated glucose utilization British Journal of Pharmacology. ,vol. 112, pp. 671- 675 ,(1994) , 10.1111/J.1476-5381.1994.TB13128.X
Eric Gontier, Emmanuelle Fourme, Myriam Wartski, Cyrille Blondet, Gerald Bonardel, Elise Le Stanc, Marina Mantzarides, Herve Foehrenbach, Alain-Paul Pecking, Jean-Louis Alberini, High and typical 18F-FDG bowel uptake in patients treated with metformin European Journal of Nuclear Medicine and Molecular Imaging. ,vol. 35, pp. 95- 99 ,(2008) , 10.1007/S00259-007-0563-6
Fredrik Bäckhed, Jill K. Manchester, Clay F. Semenkovich, Jeffrey I. Gordon, Mechanisms underlying the resistance to diet-induced obesity in germ-free mice Proceedings of the National Academy of Sciences of the United States of America. ,vol. 104, pp. 979- 984 ,(2007) , 10.1073/PNAS.0605374104